Advertisement

Myocardial metabolic imaging with fluorine-18 deoxyglucose

  • Neal G. Uren
  • Paolo G. Camici
Chapter
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 133)

Abstract

With the definition of coronary artery anatomy by angiography has come the need to characterize the pathophysiological consequences of coronary artery disease. In order to quantify the functional significance of an epicardial coronary stenosis, measurement of coronary blood flow and blood flow reserve has developed using invasive techniques such as Doppler catheterization [1] and coronary sinus thermodilution [2, 3]. Coronary sinus catheterization may also be used to measure the transmyocardial extraction of metabolic substrates by simultaneous catheterization of an artery and coronary sinus or great cardiac vein [4], However, these invasive methods are limited by their inability to measure coronary blood flow or metabolism in different myocardial regions at the same time or in regions supplied by arteries other than the left anterior descending artery in the case of coronary sinus catheterization. This is an even greater limitation if one takes into account the intrinsic regionality of ischemic heart disease.

Keywords

Positron Emission Tomography Left Anterior Descend Myocardial Blood Flow Coronary Sinus Coronary Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wilson RF, Laughlin DE, Ackell PH et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 1985; 72: 82–92.PubMedCrossRefGoogle Scholar
  2. 2.
    Ganz W, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJ. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971; 44: 181–95.PubMedCrossRefGoogle Scholar
  3. 3.
    Pepiine CJ, Mehta J, Webster WW Jr, Nichols WW. In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary artery disease. Circulation 1978; 58: 795–802.CrossRefGoogle Scholar
  4. 4.
    Bing RJ. The metabolism of the heart. Harvey Lect 1954; 50: 27–70.PubMedGoogle Scholar
  5. 5.
    Phelps ME. Emission computed tomography. Semin Nucl Med 1977; 7: 337–65.Google Scholar
  6. 6.
    Phelps ME, Hoffman EJ, Huang SC, Kuhl DE. ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. J Nucl Med 1978; 19: 635–47.PubMedGoogle Scholar
  7. 7.
    Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32: 217–38.PubMedCrossRefGoogle Scholar
  8. 8.
    Newsholme EA, Crabtree B. Theoretical principles in the approaches to control of metabolic pathways and their application to glycolysis in muscle [editorial]. J Mol Cell Cardiol 1979; 11: 839–56.PubMedCrossRefGoogle Scholar
  9. 9.
    Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785–9.Google Scholar
  10. 10.
    Camici P, Marraccini P, Marzilli M et al. Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. Am J Physiol 1989; 257: E309–17.CrossRefGoogle Scholar
  11. 11.
    Maseri A. The changing face of angina pectoris: practical implications. Lancet 1983; 1: 746–9.Google Scholar
  12. 12.
    Opie LH, Owen P, Riemersma RA. Relative rates of oxidation of glucose and free fatty acids by ischaemic and non-ischaemic myocardium after coronary artery ligation in the dog. Eur J Clin Invest 1973; 3: 419–35.Google Scholar
  13. 13.
    Rovetto MJ, Lamberton WF, Neely JR. Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ Res 1975; 37: 742–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Neely JR, Liedtke AJ, Whitmer JT, Rovetto MJ. Relationship between coronary flow and adenosine triphosphate production from glycolysis and oxidative metabolism. In: Roy EP, Harris P, editors. The cardiac sarcoplasm. München: Urban & Schwarzenberg, 1976: 301–21.Google Scholar
  15. 15.
    Bergmann SR, Fox KA, Geltman EG, Sobel BE. Positron emission tomography of the heart. Prog Cardiovasc Dis 1985; 28: 165–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Phelps ME, Hoffman EJ, Selin C et al. Investigation of [F18]2-fluoro-2-deoxyglucose for the measurement of myocardial glucose metabolism. J Nucl Med 1978; 19: 1311–9.Google Scholar
  17. 17.
    Gallagher BM, Ansari A, Atkins H et al. Radiopharmaceuticals XXVII. 18F-labelled 2-deoxy-2-fluoro-d-glucose 25 a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 1977; 18: 990–6.PubMedGoogle Scholar
  18. 18.
    Ratib O, Phelps ME, Huang SC, Henze SC, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982; 23: 577–86.PubMedGoogle Scholar
  19. 19.
    Camici P, Araujo LI, Spinks T et al. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 1986; 74: 81–8.Google Scholar
  20. 20.
    Nienaber CA, Brunken RC, Sherman CT et al. Recovery of myocardial metabolism precedes functional improvement following relief of chronic myocardial ischemia by PTCA [abstract]. J Nucl Med 1989; 30 Suppl: 838.Google Scholar
  21. 21.
    Fedele FA, Gerwirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 1988; 78: 729–3Google Scholar
  22. 22.
    Araujo LI, Camici P, Spinks TJ, Jones T, Maseri A. Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography. Cardiovasc Drugs Ther 1988; 2: 41–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Braunwald E, Kloner RA. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 1982; 66: 1146–9.Google Scholar
  24. 24.
    Tillisch J, Brunken R, Marshall R. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Marshall RC, Tillisch JH, Phelps ME et al. Identification and differentiation of resting myocardial ischemia in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67: 766–78.PubMedCrossRefGoogle Scholar
  26. 26.
    Schwaiger M, Brunken R, Grover-McKay M et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986; 8: 800–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Schwaiger M, Brunken RC, Kripokavich J et al. Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J 1987; 8: 981–8.PubMedGoogle Scholar
  28. 28.
    Pierard LA, de Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021–31.PubMedCrossRefGoogle Scholar
  29. 29.
    Tamaki N, Yonekura Y, Yamashita K et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565–78.Google Scholar
  31. 31.
    Camici P, Marraccini P, Lorenzoni R et al. Metabolic markers of stress-induced ischaemia. Circulation 1991; 83 (suppl III): III–8–III–13.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1992

Authors and Affiliations

  • Neal G. Uren
  • Paolo G. Camici

There are no affiliations available

Personalised recommendations